Academic Journal
Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase Inhibitors
| Τίτλος: | Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase Inhibitors |
|---|---|
| Συγγραφείς: | Walker, Scott S., Xu, Yiming, Triantafyllou, Ilias, Waldman, Michelle F., Mendrick, Cara, Brown, Nathaniel, Mann, Paul, Chau, Andrew, Patel, Reena, Bauman, Nicholas, Norris, Christine, Antonacci, Barry, Gurnani, Maya, Cacciapuoti, Anthony, McNicholas, Paul M., Wainhaus, Samuel, Herr, R. Jason, Kuang, Rongze, Aslanian, Robert G., Ting, Pauline C., Black, Todd A. |
| Πηγή: | Antimicrobial Agents and Chemotherapy ; volume 55, issue 11, page 5099-5106 ; ISSN 0066-4804 1098-6596 |
| Στοιχεία εκδότη: | American Society for Microbiology |
| Έτος έκδοσης: | 2011 |
| Περιγραφή: | The echinocandins are a class of semisynthetic natural products that target β-1,3-glucan synthase (GS). Their proven clinical efficacy combined with minimal safety issues has made the echinocandins an important asset in the management of fungal infection in a variety of patient populations. However, the echinocandins are delivered only parenterally. A screen for antifungal bioactivities combined with mechanism-of-action studies identified a class of piperazinyl-pyridazinones that target GS. The compounds exhibited in vitro activity comparable, and in some cases superior, to that of the echinocandins. The compounds inhibit GS in vitro , and there was a strong correlation between enzyme inhibition and in vitro antifungal activity. In addition, like the echinocandins, the compounds caused a leakage of cytoplasmic contents from yeast and produced a morphological response in molds characteristic of GS inhibitors. Spontaneous mutants of Saccharomyces cerevisiae with reduced susceptibility to the piperazinyl-pyridazinones had substitutions in FKS1 . The sites of these substitutions were distinct from those conferring resistance to echinocandins; likewise, echinocandin-resistant isolates remained susceptible to the test compounds. Finally, we present efficacy and pharmacokinetic data on an example of the piperazinyl-pyridazinone compounds that demonstrated efficacy in a murine model of Candida glabrata infection. |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| DOI: | 10.1128/aac.00432-11 |
| DOI: | 10.1128/AAC.00432-11 |
| Διαθεσιμότητα: | https://doi.org/10.1128/aac.00432-11 https://journals.asm.org/doi/pdf/10.1128/AAC.00432-11 |
| Rights: | https://journals.asm.org/non-commercial-tdm-license |
| Αριθμός Καταχώρησης: | edsbas.D19DD6FA |
| Βάση Δεδομένων: | BASE |
καταχωρήστε σχόλιο πρώτοι!